BNP Paribas Financial Markets’s Applied Therapeutics APLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-2,974
| Closed | -$297 | – | 5822 |
|
|
2025
Q4 | $297 | Sell |
2,974
-501
| -14% | -$318 | ﹤0.01% | 5528 |
|
|
2025
Q3 | $2.1K | Sell |
3,475
-4,724
| -58% | -$2.23K | ﹤0.01% | 5165 |
|
|
2025
Q2 | $2.55K | Sell |
8,199
-2,652
| -24% | -$1.03K | ﹤0.01% | 5029 |
|
|
2025
Q1 | $5.3K | Sell |
10,851
-163,800
| -94% | -$96.4K | ﹤0.01% | 4845 |
|
|
2024
Q4 | $150K | Buy |
174,651
+39,379
| +29% | +$247K | ﹤0.01% | 4017 |
|
|
2024
Q3 | $1.15M | Buy |
135,272
+128,353
| +1,855% | +$756K | ﹤0.01% | 2409 |
|
|
2024
Q2 | $32.3K | Buy |
6,919
+6,918
| +691,800% | +$32.7K | ﹤0.01% | 3563 |
|
|
2024
Q1 | $7 | Hold |
1
| – | – | ﹤0.01% | 4014 |
|
|
2023
Q4 | $3 | Sell |
1
-1,632
| -100% | -$4.06K | ﹤0.01% | 3992 |
|
|
2023
Q3 | $4.07K | Hold |
1,633
| – | – | ﹤0.01% | 3676 |
|
|
2023
Q2 | $2.09K | Sell |
1,633
-37
| -2% | -$49 | ﹤0.01% | 3726 |
|
|
2023
Q1 | $1.35K | Sell |
1,670
-1,451
| -46% | -$1.43K | ﹤0.01% | 3661 |
|
|
2022
Q4 | $2.37K | Buy |
3,121
+2,481
| +388% | +$1.96K | ﹤0.01% | 3724 |
|
|
2022
Q3 | $595 | Sell |
640
-22,314
| -97% | -$26.8K | ﹤0.01% | 4499 |
|
|
2022
Q2 | $21.8K | Buy |
22,954
+21,415
| +1,391% | +$35.1K | ﹤0.01% | 3688 |
|
|
2022
Q1 | $3.25K | Sell |
1,539
-3,311
| -68% | -$8.87K | ﹤0.01% | 3880 |
|
|
2021
Q4 | $43.4K | Buy |
4,850
+1,715
| +55% | +$22.5K | ﹤0.01% | 3762 |
|
|
2021
Q3 | $52K | Buy |
3,135
+2,367
| +308% | +$40.9K | ﹤0.01% | 3512 |
|
|
2021
Q2 | $16K | Sell |
768
-1,249
| -62% | -$23.6K | ﹤0.01% | 3598 |
|
|
2021
Q1 | $37.8K | Sell |
2,017
-535
| -21% | -$11.5K | ﹤0.01% | 3672 |
|
|
2020
Q4 | $56.2K | Sell |
2,552
-615
| -19% | -$12.8K | ﹤0.01% | 3501 |
|
|
2020
Q3 | $65.7K | Buy |
3,167
+2,648
| +510% | +$68.8K | ﹤0.01% | 3334 |
|
|
2020
Q2 | $18.8K | Sell |
519
-1,936
| -79% | -$81K | ﹤0.01% | 3426 |
|
|
2020
Q1 | $80.3K | Buy |
2,455
+1,345
| +121% | +$54.4K | ﹤0.01% | 3321 |
|
|
2019
Q4 | $30.3K | Buy |
1,110
+1,050
| +1,750% | +$18K | ﹤0.01% | 3879 |
|
|
2019
Q3 | $659 | Buy |
+60
| New | +$566 | ﹤0.01% | 4414 |
|
BNP Paribas Financial Markets's APLT Position: Q1 2026 in Review
BNP Paribas Financial Markets sold out of Applied Therapeutics (APLT) in Q1 2026, closing a stake of 2,974 shares — an estimated $297 sold.
BNP Paribas Financial Markets first reported a position in APLT in Q3 2019 and held it in 26 quarters. The position peaked at $1.15M in Q3 2024. 0 funds tracked by Wall St. Rank hold APLT as of Q1 2026.
- BNP Paribas Financial Markets reported no remaining Applied Therapeutics position as of Q1 2026 after selling out during the quarter.
- BNP Paribas Financial Markets sold 2,974 Applied Therapeutics shares in Q1 2026, an estimated $297.
- BNP Paribas Financial Markets first reported a position in Applied Therapeutics in Q3 2019 and held it in 26 quarters.
- BNP Paribas Financial Markets's Applied Therapeutics position peaked at $1.15M in Q3 2024.
- 0 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.